Showing results (31-40 of 148) with videos related to
Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2012
Mimicking an induced self phenotype by coating lymphomas with the NKp30 ligand B7-H6 promotes NK cell cytotoxicityChristian Kellner, Tina Maurer, Daniela Hallack, et al.Mabs|February 5, 2014
Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2m(1) antibodyChristina Brunke, Stefan Lohse, Stefanie Derer, et al.The Journal of Biological Chemistry|June 9, 2012
Characterization of a mutated IgA2 antibody of the m(1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophagesStefan Lohse, Christina Brunke, Stefanie Derer, et al.Journal of Clinical Medicine|July 2, 2021
Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In VivoDorothee Winterberg, Lennart Lenk, Maren Oßwald, et al.Melanoma Research|March 14, 2008
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cellsMichael Schwenkert, Katrin Birkholz, Michael Schwemmlein, et al.Best Practice & Research. Clinical Haematology|June 11, 2011
Molecular engineering to improve antibodies' anti-lymphoma activityMatthias Peipp, Jan G J van de Winkel, Thomas ValeriusBlood|July 13, 2017
An Fc-engineered CD19 antibody eradicates MRD in patient-derived MLL-rearranged acute lymphoblastic leukemia xenograftsDenis M Schewe, Ameera Alsadeq, Cornelia Sattler, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2014
Epidermal growth factor receptor targeting IgG3 triggers complement-mediated lysis of decay-accelerating factor expressing tumor cells through the alternative pathway amplification loopThies Rösner, Stefan Lohse, Matthias Peipp, et al.Archivum Immunologiae Et Therapiae Experimentalis|May 29, 2010
Impact of human IgA antibodies on complement-dependent cytotoxicity mediated by combinations of EGF-R-directed antibodiesStefan Lohse, Matthias Peipp, Thomas Beyer, et al.Antibodies (Basel, Switzerland)|November 20, 2020
Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-EngineeringSophia Roßkopf, Klara Marie Eichholz, Dorothee Winterberg, et al.Pageof 15